Maintaining CI’s 20/20 focus during a pandemic year
Competitive Intelligence (CI) is fundamental to ensuring the success of Pharma companies, whether they are planning a new drug or are already an established presence in the market. Alongside research and development, CI is crucial to businesses that want to maximise the value of their science.
In 2019, Prescient launched an industry study into challenges within CI, and appropriate objectives, strategies and outcomes for CI professionals to put to use. In 2020, the study has nearly doubled in size to include a more diverse range of insights from some of the industry’s leading CI practitioners.
On Tuesday, September 22 at 8:00 AM ET and Wednesday, September 23 at 1:00 PM ET we will be presenting a webinar that previews the latest findings of the Prescient Competitive Intelligence Report 2020 prior to full publication.
Join Mark Little, Senior Vice President, Intelligence & Insight at Prescient Healthcare Group as he highlights the key research findings in this exclusive interactive webinar. Attending the session live will allow you the opportunity to put your questions to Mark and be among the first to receive a complimentary copy of the Prescient Competitive Intelligence Report 2020.
In this webinar you will learn:
- Highlights from the top ten challenges for CI professionals in 2020
- How the landscape has changed since our previous survey in 2019
- Strategies and responses appropriate for a post-COVID world
To reserve your place, register using the form.